Role of persistent amenorrhea in bone mineral metabolism of young hemodialyzed women

Kidney International

Volumn 58, Issue 1, 2000, Pages 331-335

  Weisinger, José R ^a   Gonzalez, Leyda ^a   Alvarez, Hector ^a   Hernandez, Eddy ^a   Carlini, Raúl G ^a   Capriles, Freya ^a   Cerviño, Mercedes ^a   Martinis, Ruby ^a   Paz Martínez, Virgilio ^a   Bellorín Font, Ezequiel ^a  

^a HOSPITAL UNIVERSITARIO DE CARACAS   (Venezuela)

Author keywords

Anovoluatory cycles; Bone mineral density; Estrogen replacement; Menopause; Osteoporosis

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; PARATHYROID HORMONE; PHOSPHATE; PROCOLLAGEN C PROTEINASE;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; AMENORRHEA; ARTICLE; BONE METABOLISM; BONE MINERAL; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; HEMODIALYSIS; HUMAN; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; TRABECULAR BONE;

EID: 0033934616     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00170.x     Document Type: Article

References (28)

1. 1. GOODMAN WG, COBURN JW, SLATOPOLSKY E, SALUSKY IB: Renal osteodystrophy in adults and children, in Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism (3rd ed), edited by FAVUS MJ, Philadelphia, New York, Lippincott-Raven, 1996, pp 324-360
2. 2. LINDBERG JS, MOE SM: Osteoporosis in end stage renal disease. Semin Nephrol 19:115-122, 1999
3. 3. CANNATA-ANDIA JB: Hypokinetic azotemic osteodystrophy. Kidney Int 54:1000-1016, 1998
4. 4. SILVER J, EPSTEIN E, NAVEH-MANY T: Estrogen deficiency: Does it have a role in the genesis of skeletal problems in dialyzed women? Nephrol Dial Transplant 11:565-566, 1996
5. 5. PACIFICI R, RIFAS L, MCCRACKEN R, VERED I, MCMURTRY C, AVIOLI LV, PECK WA: Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. Proc Natl Acad Sci USA 86:2398-2402, 1989
6. 6. RALSTON SH: Analysis of gene expression in human bone biopsies by polymerese chain reaction: Evidence for enhanced cytokine expression in postmenopausal osteoporosis. J Bone Miner Res 9: 883-890, 1994
7. 7. JONES TH: Interleukin-6 an endocrine cytokine. Clin Endocrinol 40:703-713, 1994
8. 8. JILKA RL, HANGOC G, GIRASOLE G, PASSERI G, WILLIAMS DC, ABRAMS JS, BOYCE B, BROXMEYER H, MANOLAGAS SC: Increased osteoclast development after estrogen loss: Mediation by interleukin-6. Science 257:88-91, 1992
9. 9. HOROWITZ M: Cytokines and estrogen in bone: Anti-osteoporotic effects. Science 260:626-627, 1993
10. 10. LUGER A, KOVARIK J, STUMMVOLL HK, URBANSKA A, LUGER T: Blood membrane interaction in hemodialysis leads to increased cytokine production. Kidney Int 32:84-88, 1987
11. 11. PEREIRA BJG, SHAPIRO L, KING AJ, FALAGAS ME, STROM JA, DINARELLO CA: Plasma levels of IL-1β, TNFα and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients. Kidney Int 45:890-896, 1993
12. 12. KITAZAWA R, KIMBLE RB, VANNICE JL, KUNG VL, PACIFICI R: Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice. J Clin Invest 94:2397-2406, 1994
13. 13. NAVEH-MANY T, ALMOGI G, LIVNI N, SILVER J: Estrogen receptors, and biologic response in rat parathyroid tissue and C-cells. J Clin Invest 90:2434-2438, 1992
14. 14. LIM VS, HENRIQUEZ C, SIEVERSTEN G, FROHMAN LA: Ovarian function in chronic renal failure: Evidence of hypothalamic anovulation. Ann Intern Med 92:21-27, 1980
15. 15. LIM VS, KATHPALIA SC, FROHMAN LA: Hyperprolactinemia and impaired pituitary response to suppression and stimulation in chronic renal failure: Reversal after transplantation. J Clin Endocrinol Metab 48:101-107, 1979
16. 16. COCHRANE R, REGAN L: Undetected gynecological disorders in women with renal disease. Hum Reprod 12:667-670, 1997
17. 17. HOLLEY JL, SCHMIDT RJ, BENDER FH, DUMIER F, SCHIFF M: Gynecological and reproductive issues in women on dialysis. Am J Kidney Dis 29:685-690, 1997
18. 18. PRIOR JC, VIGNA YM, SCHECHTER MT, BURGESS AE: Spinal bone loss and anovulatory disturbances. N Engl J Med 323:1221-1227, 1990
19. 19. SCHACHTER M, SHOHAM Z: Amenorrhea during the reproductive years: Is it safe? Fertil Steril 62:1-16, 1994
20. 20. RUSSO CR, TACCETTI G, CANEVA P, MANNARINO A, MARANGHI P, RICCA M: Volumetric bone density and geometric assessed by peripheral quantitative computed tomography in uremic patients on maintenance hemodialysis. Osteoporos Int 8:443-448, 1998
21. 21. GINSBURG ES, OWEN WF JR, GREENBERG L, SHEA BF, LAZARUS M, WALSH BW: Estrogen absorption and metabolism in postmenopausal women with end-stage renal disease. J Clin Endocrinol Metab 81:4414-4417, 1996
22. 22. GARNERO P, SHIH W, GINEYTS E, KARPF D, DELMAS P: Comparison of new biochemical markers of bone turnover in late post-menopausal osteoportic women in response to alendronate treatment. J Clin Endocrinol Metab 79:1693-1700, 1994
23. 23. PANTEGHINI M, PAGANI F: Biological variation in bone-derived biochemical markers in serum. Scand J Clin Lab Invest 55:609-616, 1995
24. 24. UREÑA P, VERNEJOUL MC: Circulating biochemical markers of bone remodeling in uremic patients. Kidney Int 55:2141-2156, 1999
25. 25. KANATANI M, SUGIMOTO T, TAKAHASHI Y, KAJI H, KITAZAWA R, CHICHAHARA K: Estrogen via the estrogen receptor blocks cAMP-mediated parathyroid hormone (PTH)-stimulated osteoclast formation. J Bone Miner Res 13:854-862, 1998
26. 26. MATUSZKIEWICZ-ROWIÑSKA J, SKORZEWSKA K, RADOWICKI S, SOKALSKI A, PRZEDLACKI J, NIEMCZYK S, WLODARCZYK D, PUKA J, SWITALSKI M: The benefits of hormone replacement therapy in premenopausal women with oestrogen deficiency on haemodialysis. Nephrol Dial Transplant 14:1238-1243, 1999
27. 27. GINSBURG ES, WALSH B, GREENBERG L, PRICE D, CHERTOW GM, OWEN WF JR: Effect of estrogen replacement therapy on the lipoprotein profile in postmenopausal women with ESRD. Kidney Int 54:1344-1350, 1998
28. 28. SLEMENDA CW, LONGCOPE C, ZHOU L, HUI SL, PEACKOCK M, JOHNSTON CC: Sex steroids and bone mass in older men: Positive associations with serum estrogens and negative associations with androgens. J Clin Invest 100:1755-1759, 1997